Research Analysts Set Expectations for Teleflex Q3 Earnings

Teleflex Incorporated (NYSE:TFX) – Investment analysts at Zacks Research decreased their Q3 2026 earnings estimates for Teleflex in a report issued on Monday, December 15th. Zacks Research analyst Team now forecasts that the medical technology company will post earnings of $3.88 per share for the quarter, down from their previous estimate of $3.90. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q3 2027 earnings at $4.29 EPS.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, beating the consensus estimate of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The business had revenue of $892.90 million during the quarter, compared to analyst estimates of $892.79 million. During the same quarter last year, the business earned $3.49 earnings per share. Teleflex’s quarterly revenue was up 19.4% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS.

Other equities research analysts also recently issued reports about the company. Royal Bank Of Canada restated a “sector perform” rating and set a $135.00 price objective on shares of Teleflex in a research report on Wednesday. Truist Financial increased their price target on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a report on Thursday. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research report on Monday. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Tuesday, December 9th. One analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Teleflex currently has an average rating of “Reduce” and a consensus target price of $142.43.

Teleflex Trading Down 0.5%

TFX opened at $124.50 on Wednesday. The firm has a market cap of $5.50 billion, a P/E ratio of -16.94, a P/E/G ratio of 1.49 and a beta of 0.95. Teleflex has a 12 month low of $102.58 and a 12 month high of $185.94. The company has a current ratio of 2.57, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. The stock has a 50-day moving average of $120.09 and a 200 day moving average of $121.02.

Institutional Investors Weigh In On Teleflex

Large investors have recently added to or reduced their stakes in the stock. T. Rowe Price Investment Management Inc. increased its position in shares of Teleflex by 0.7% during the first quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company’s stock worth $859,095,000 after acquiring an additional 43,642 shares during the period. AQR Capital Management LLC grew its stake in Teleflex by 478.1% in the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after purchasing an additional 1,956,811 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Teleflex by 0.3% in the third quarter. Dimensional Fund Advisors LP now owns 1,245,614 shares of the medical technology company’s stock worth $152,408,000 after purchasing an additional 3,812 shares in the last quarter. Cooke & Bieler LP increased its holdings in Teleflex by 1.2% during the 3rd quarter. Cooke & Bieler LP now owns 1,220,637 shares of the medical technology company’s stock worth $149,357,000 after purchasing an additional 14,673 shares during the period. Finally, Abrams Bison Investments LLC bought a new stake in Teleflex during the 3rd quarter valued at $112,317,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend was Friday, November 14th. Teleflex’s dividend payout ratio (DPR) is currently -18.50%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.